MyFinsight
Home
Blog
About
Net loss, basic
-$12,158K
(-117.77%↓ Y/Y)
Net loss
-$12,158K
(-117.77%↓ Y/Y)
US
$28,220K
(18.10%↑ Y/Y)
EMEA
$11,304K
(-8.16%↓ Y/Y)
Asia Pacific
$7,915K
(0.61%↑ Y/Y)
Other
$701K
(-54.24%↓ Y/Y)
Loss before income
taxes
-$11,643K
Provision for (benefit
from) income taxes
$515K
(143.20%↑ Y/Y)
Total revenue, net
$48,140K
(5.57%↑ Y/Y)
Loss from operations
-$11,400K
(-7.30%↓ Y/Y)
Total other income
(expense), net
-$243K
(-106.31%↓ Y/Y)
Gross profit
$28,340K
(18.74%↑ Y/Y)
Interest income
$819K
(47.57%↑ Y/Y)
Total cost of sales
$19,800K
(-8.90%↓ Y/Y)
Total operating
expenses
$39,740K
(15.22%↑ Y/Y)
Other income
(expense), net
-$781K
(-121.06%↓ Y/Y)
Interest expense
$281K
(-32.13%↓ Y/Y)
General and
administrative
$16,825K
(24.34%↑ Y/Y)
Sales and marketing
$13,174K
(8.57%↑ Y/Y)
Research and development
$9,741K
(10.37%↑ Y/Y)
Back
Back
Income Statement
Cytek Biosciences, Inc. (CTKB)
Cytek Biosciences, Inc. (CTKB)
source: myfinsight.com